
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
EDITORIAL article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1569255
This article is part of the Research Topic Diagnosis and Treatment of Vulvar Cancer View all 7 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
A study by Tadele Emagneneh et al. highlights several persistent issues in vulvar cancer management. One of the major global challenges discussed is the lower survival rates for cervical cancer in regions such as Sub-Saharan Africa, where access to preventive screening, early detection, and treatment remains limited. The systematic review reveals that survival rates can be less than 35%, underscoring the disparities in healthcare access. Though vulvar and cervical cancers have distinct etiologies, this study underscores the broader issue of healthcare infrastructure and the need for international collaboration to improve prevention, diagnosis, and treatment access. Efforts to improve HPV vaccination, screening, and early intervention strategies can similarly benefit vulvar cancer care, especially in underserved areas.
Keywords: vulvar cancer, HPV, Radiotherapy, biomarkers, Molecular profiling, gynecologic oncology, Early detection, personalized medicine
Received: 31 Jan 2025; Accepted: 24 Feb 2025.
Copyright: © 2025 Di Donato, Golia D'Augè, Bogani and Giannini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Andrea Giannini, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, 00189, Lazio, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.